Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M609335200 on May 31, 2007

J. Biol. Chem., Vol. 282, Issue 37, 27315-27326, September 14, 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
282/37/27315    most recent
M609335200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Borland, G.
Right arrow Articles by Cushley, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Borland, G.
Right arrow Articles by Cushley, W.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

{alpha}vbeta5 Integrin Sustains Growth of Human Pre-B Cells through an RGD-independent Interaction with a Basic Domain of the CD23 Protein*

Gillian Borland{ddagger}1, Adrienne L. Edkins{ddagger}2, Mridu Acharya{ddagger}2, Johanne Matheson{ddagger}, Lindsey J. White{ddagger}3, Janet M. Allen§, Jean-Yves Bonnefoy, Bradford W. Ozanne||4, and William Cushley{ddagger}5

From the {ddagger}Division of Biochemistry & Molecular Biology, Institute of Biomedical & Life Sciences, University of Glasgow, University Avenue, Glasgow G12 8QQ, Scotland, United Kingdom, the ||Cancer Research UK Beatson Laboratories, Switchback Road, Glasgow G61 1BD, Scotland, United Kingdom, §Conway Institute, University College Dublin, Dublin 4, Ireland, and Transgene, 67028 Strasbourg, France

CD23 is a type II transmembrane glycoprotein synthesized by hematopoietic cells that has biological activity in both membrane-bound and freely soluble forms, acting via a number of receptors, including integrins. We demonstrate here that soluble CD23 (sCD23) sustains growth of human B cell precursors via an RGD-independent interaction with the {alpha}vbeta5 integrin. The integrin recognizes a tripeptide motif in a small disulfide-bonded loop at the N terminus of the lectin head region of CD23, centered around Arg172, Lys173, and Cys174 (RKC). This RKC motif is present in all forms of sCD23 with cytokine-like activity, and cytokine activity is independent of the lectin head, an "inverse RGD" motif, and the CD21 and IgE binding sites. RKC-containing peptides derived from this region of CD23 bind {alpha}vbeta5 and are biologically active. The binding and activity of these peptides is unaffected by inclusion of a short peptide containing the classic RGD sequence recognized by integrins, and, in far-Western analyses, RKC-containing peptides bind to the beta subunit of the {alpha}vbeta5 integrin. The interaction between {alpha}vbeta5 and sCD23 indicates that integrins deliver to cells important signals initiated by soluble ligands without the requirement for interactions with RGD motifs in their common ligands. This mode of integrin signaling may not be restricted to {alpha}vbeta5.


Received for publication, October 2, 2006 , and in revised form, May 30, 2007.

* This work was supported in part by project grants from the Biotechnology & Biological Sciences Research Council (BBSRC), the Leukemia Research Fund, and the Arthritis Research Campaign. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 Supported by a Wellcome Trust Value in People award.

2 Supported by the Wellcome Trust PhD program, Molecular Functions in Disease.

3 Supported by a post-graduate scholarship from the BBSRC.

4 Supported by Cancer Research UK.

5 To whom correspondence should be addressed. Tel.: 44-141-330-5261; Fax: 44-141-330-4620; E-mail: W.Cushley{at}bio.gla.ac.uk.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement